Reversed visual field constrictions in children after vigabatrin withdrawal - True retinal recovery or improved test performance only?

Seizure

Volumn 10, Issue 7, 2001, Pages 508-511

  Vanhatalo, S ^a   Alen, R ^b   Riikonen, R ^c   Rantala, H ^d   Aine, M R ^e   Mustonen, K ^f   Nousiainen, I ^g  

^a UNIVERSITY OF HELSINKI   (Finland)

^b JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e LAPLAND CENTRAL HOSPITAL   (Finland)

^f NORTH KARELIA CENTRAL HOSPITAL   (Finland)

^g KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Children; Epilepsy; Vigabatrin; Visual field constriction

Indexed keywords

CARBAMAZEPINE; DIAZEPAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; PERIMETRY; PRIORITY JOURNAL; RETINA; TASK PERFORMANCE; VISUAL ACUITY; VISUAL FIELD DEFECT; VISUAL SYSTEM EXAMINATION;

EID: 0035692825     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1053/seiz.2001.0544     Document Type: Article

References (15)

1. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects
2. Vigabatrin-associated retinal cone system dysfunction: Electroretinogram and ophthalmologic findings
3. Visual field constriction in children treated with vigabatrin
4. Visual field constriction is not limited to children treated with vigabatrin
5. Visual field constriction in children with epilepsy on vigabatrin treatment
6. Visual field defects associated with vigabatrin monotherapy in children
7. Visual fields in 4- to 10-year-old children using Goldmann and double-arc perimeters
8. Visual function loss from vigabatrin: Effect of stopping the drug
9. Recovery of visual field constriction following discontinuation of vigabatrin
10. Reversibility of vigabatrin-induced visual-field defect
11. Another case of reversibility of visual-field defect induced by vigabatrin monotherapy: Is young age a favorable factor?
12. Preschool vision screening: Summary of a task force report
13. Visual dysfunction in patients receiving vigabatrin: Clinical and electrophysiologic findings
14. Contrast and glare sensitivity in epilepsy patients treated with vigabatrin or carbamazepine monotherapy compared with healthy volunteers
15. The amblyopic schoolgirl syndrome